Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs
Medicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.